Although Ras mutations are rare in breast cancer, KRas is one of the most frequently altered genes across tumor types20,21, persistent activation of Ras is seen in many breast cancer cell lines30, and components of the Ras signaling pathway (e.g. ERK) are mutated or highly activated in breast cancer31,32. Here, KRAS is linked to breast carcinoma.